Mesoblast (MESO) announced its upcoming addition to the Nasdaq Biotechnology Index (NBI) as part of the annual reconstitution of the 2024 Nasdaq index. Mesoblast’s inclusion in the NBI will be effective after the U.S. market opens on Monday, December 23, 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MESO:
Questions or Comments about the article? Write to editor@tipranks.com